(Q46570608)

English

Multiple-dose pharmacokinetics, pharmacodynamics, and safety of taranabant, a novel selective cannabinoid-1 receptor inverse agonist, in healthy male volunteers

scientific article published in June 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18508950

Multiple-dose pharmacokinetics, pharmacodynamics, and safety of taranabant, a novel selective cannabinoid-1 receptor inverse agonist, in healthy male volunteers (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18508950

0 references

0 references

cannabinoid receptor

0 references

pharmacodynamics

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

Inge De Lepeleire

14

object named as

Inge De Lepeleire

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18508950

17

object named as

Marleen Depré

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18508950

Paul Rothenberg

2

object named as

Paul Rothenberg

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18508950

20

object named as

Aubrey Stoch

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18508950

Anne-Josée Côté

11

object named as

Josee Cote

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18508950

Keith Gottesdiener

19

object named as

Keith Gottesdiener

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18508950

author name string

Carol Addy

1

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18508950

Susie Li

3

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18508950

Anup Majumdar

4

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18508950

Nancy Agrawal

5

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18508950

Hankun Li

6

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18508950

Ling Zhong

7

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18508950

Jinyu Yuan

8

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18508950

Andrea Maes

9

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18508950

Stephanie Dunbar

10

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18508950

Kim Rosko

12

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18508950

Kristien Van Dyck

13

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18508950

Jan de Hoon

15

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18508950

Anne Van Hecken

16

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18508950

Annemie Knops

18

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18508950

John Wagner

21

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18508950

publication date

1 June 2008

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18508950

The Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18508950

48

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18508950

6

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18508950

734-744

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18508950

State-level estimates of annual medical expenditures attributable to obesity

1 reference

https://api.crossref.org/works/10.1177%2F0091270008317591

21 January 2018

Rimonabant--a selective CB1 antagonist

1 reference

https://api.crossref.org/works/10.1177%2F0091270008317591

21 January 2018

The endocannabinoid system and its therapeutic exploitation

1 reference

https://api.crossref.org/works/10.1177%2F0091270008317591

21 January 2018

The endocannabinoid system: a general view and latest additions

1 reference

https://api.crossref.org/works/10.1177%2F0091270008317591

21 January 2018

The role of the endocannabinoid system in the control of energy homeostasis.

1 reference

https://api.crossref.org/works/10.1177%2F0091270008317591

21 January 2018

Endocannabinoid signaling system and brain reward: emphasis on dopamine

1 reference

https://api.crossref.org/works/10.1177%2F0091270008317591

21 January 2018

Effects of SR141716A, a central cannabinoid receptor antagonist, on food-maintained responding.

1 reference

https://api.crossref.org/works/10.1177%2F0091270008317591

21 January 2018

Antiobesity efficacy of a novel cannabinoid-1 receptor inverse agonist, N-[(1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-[[5-(trifluoromethyl)pyridin-2-yl]oxy]propanamide (MK-0364), in rodents

1 reference

https://api.crossref.org/works/10.1177%2F0091270008317591

21 January 2018

The role of endogenous cannabinoids in the hypothalamo-pituitary-adrenal axis regulation: in vivo and in vitro studies in CB1 receptor knockout mice

1 reference

https://api.crossref.org/works/10.1177%2F0091270008317591

21 January 2018

Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamic-pituitary-adrenal axis

1 reference

https://api.crossref.org/works/10.1177%2F0091270008317591

21 January 2018

Opioid and cannabinoid receptor-mediated regulation of the increase in adrenocorticotropin hormone and corticosterone plasma concentrations induced by central administration of delta(9)-tetrahydrocannabinol in rats

1 reference

https://api.crossref.org/works/10.1177%2F0091270008317591

21 January 2018

Effect of the brain constituent anandamide, a cannabinoid receptor agonist, on the hypothalamo-pituitary-adrenal axis in the rat.

1 reference

https://api.crossref.org/works/10.1177%2F0091270008317591

21 January 2018

Identifiers

10.1177/0091270008317591

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18508950

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18508950

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46570608&oldid=2144477750"